
Mark L. Berch
Examiner (ID: 5655)
| Most Active Art Unit | 1202 |
| Art Unit(s) | 1202, 1614, 1802, 1622, 1611, 1624, 2899 |
| Total Applications | 3573 |
| Issued Applications | 2301 |
| Pending Applications | 170 |
| Abandoned Applications | 1103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1426551
[patent_doc_number] => 06504026
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-01-07
[patent_title] => 'Process for production of ceftiofur'
[patent_app_type] => B2
[patent_app_number] => 09/989557
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1780
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/504/06504026.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989557
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989557 | Process for production of ceftiofur | Nov 19, 2001 | Issued |
Array
(
[id] => 5924009
[patent_doc_number] => 20020115852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates'
[patent_app_type] => new
[patent_app_number] => 10/014719
[patent_app_country] => US
[patent_app_date] => 2001-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14886
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20020115852.pdf
[firstpage_image] =>[orig_patent_app_number] => 10014719
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/014719 | Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates | Nov 12, 2001 | Abandoned |
Array
(
[id] => 5969345
[patent_doc_number] => 20020091252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates'
[patent_app_type] => new
[patent_app_number] => 10/014651
[patent_app_country] => US
[patent_app_date] => 2001-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14829
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20020091252.pdf
[firstpage_image] =>[orig_patent_app_number] => 10014651
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/014651 | Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates | Nov 12, 2001 | Issued |
Array
(
[id] => 5874827
[patent_doc_number] => 20020049218
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Purine derivatives having, in particular, antiproliferative properties, and their biological uses'
[patent_app_type] => new
[patent_app_number] => 09/986329
[patent_app_country] => US
[patent_app_date] => 2001-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7294
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049218.pdf
[firstpage_image] =>[orig_patent_app_number] => 09986329
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/986329 | Purine derivatives having, in particular, antiproliferative properties, and their biological uses | Nov 7, 2001 | Abandoned |
Array
(
[id] => 1419899
[patent_doc_number] => 06518420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-02-11
[patent_title] => 'Precipitation process of 7-aminocephalosporanic acid (7-ACA)'
[patent_app_type] => B2
[patent_app_number] => 10/035638
[patent_app_country] => US
[patent_app_date] => 2001-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2547
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/518/06518420.pdf
[firstpage_image] =>[orig_patent_app_number] => 10035638
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/035638 | Precipitation process of 7-aminocephalosporanic acid (7-ACA) | Nov 6, 2001 | Issued |
Array
(
[id] => 6452955
[patent_doc_number] => 20020177711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-28
[patent_title] => 'Substituted pyridyl amine ligands'
[patent_app_type] => new
[patent_app_number] => 09/993031
[patent_app_country] => US
[patent_app_date] => 2001-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 37327
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20020177711.pdf
[firstpage_image] =>[orig_patent_app_number] => 09993031
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/993031 | Phosphino substituted pyridine amine ligands | Nov 5, 2001 | Issued |
Array
(
[id] => 7469615
[patent_doc_number] => 20040102458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Small molecule compositions for binding to hsp90'
[patent_app_type] => new
[patent_app_number] => 10/415868
[patent_app_country] => US
[patent_app_date] => 2003-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11373
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102458.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415868
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415868 | Small molecule compositions for binding to hsp90 | Oct 31, 2001 | Issued |
Array
(
[id] => 6622473
[patent_doc_number] => 20020065262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Crystalline beta-lactam intermediate'
[patent_app_type] => new
[patent_app_number] => 10/001544
[patent_app_country] => US
[patent_app_date] => 2001-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4332
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20020065262.pdf
[firstpage_image] =>[orig_patent_app_number] => 10001544
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/001544 | Crystalline β-lactam intermediate | Oct 30, 2001 | Issued |
Array
(
[id] => 6818301
[patent_doc_number] => 20030069259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents'
[patent_app_type] => new
[patent_app_number] => 09/998976
[patent_app_country] => US
[patent_app_date] => 2001-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44168
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20030069259.pdf
[firstpage_image] =>[orig_patent_app_number] => 09998976
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/998976 | Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents | Oct 30, 2001 | Issued |
| 09/890500 | Immunosuppressive effects of pteridine derivatives | Oct 29, 2001 | Abandoned |
Array
(
[id] => 6721567
[patent_doc_number] => 20030055257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Water-soluble rhodamine dye conjugates'
[patent_app_type] => new
[patent_app_number] => 10/007253
[patent_app_country] => US
[patent_app_date] => 2001-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 30570
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055257.pdf
[firstpage_image] =>[orig_patent_app_number] => 10007253
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/007253 | Water-soluble rhodamine dye conjugates | Oct 23, 2001 | Abandoned |
Array
(
[id] => 1224126
[patent_doc_number] => 06699861
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-02
[patent_title] => 'Anti-quinazoline compounds'
[patent_app_type] => B1
[patent_app_number] => 09/914010
[patent_app_country] => US
[patent_app_date] => 2001-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29457
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 741
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/699/06699861.pdf
[firstpage_image] =>[orig_patent_app_number] => 09914010
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/914010 | Anti-quinazoline compounds | Oct 18, 2001 | Issued |
Array
(
[id] => 6830409
[patent_doc_number] => 20030181467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same'
[patent_app_type] => new
[patent_app_number] => 09/982351
[patent_app_country] => US
[patent_app_date] => 2001-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7233
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181467.pdf
[firstpage_image] =>[orig_patent_app_number] => 09982351
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/982351 | Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same | Oct 17, 2001 | Issued |
Array
(
[id] => 6442194
[patent_doc_number] => 20020128469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Beta-lactam production'
[patent_app_type] => new
[patent_app_number] => 09/975436
[patent_app_country] => US
[patent_app_date] => 2001-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10408
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128469.pdf
[firstpage_image] =>[orig_patent_app_number] => 09975436
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/975436 | -lactam production | Oct 10, 2001 | Issued |
Array
(
[id] => 7453338
[patent_doc_number] => 20040067929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Pharmaceutical compositions containing oxapenem-3-carboxylic acids'
[patent_app_type] => new
[patent_app_number] => 10/399704
[patent_app_country] => US
[patent_app_date] => 2003-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7977
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20040067929.pdf
[firstpage_image] =>[orig_patent_app_number] => 10399704
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/399704 | Pharmaceutical compositions containing oxapenem-3-carboxylic acids | Oct 10, 2001 | Issued |
Array
(
[id] => 1363219
[patent_doc_number] => 06569847
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-27
[patent_title] => 'Substituted azetidin-2-ones as cysteine protease inhibitors'
[patent_app_type] => B1
[patent_app_number] => 09/958141
[patent_app_country] => US
[patent_app_date] => 2001-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13600
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 928
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/569/06569847.pdf
[firstpage_image] =>[orig_patent_app_number] => 09958141
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/958141 | Substituted azetidin-2-ones as cysteine protease inhibitors | Oct 4, 2001 | Issued |
Array
(
[id] => 7609705
[patent_doc_number] => 06998484
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-14
[patent_title] => 'Synthesis of purine locked nucleic acid analogues'
[patent_app_type] => utility
[patent_app_number] => 09/971364
[patent_app_country] => US
[patent_app_date] => 2001-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8653
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/998/06998484.pdf
[firstpage_image] =>[orig_patent_app_number] => 09971364
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/971364 | Synthesis of purine locked nucleic acid analogues | Oct 3, 2001 | Issued |
Array
(
[id] => 6535494
[patent_doc_number] => 20020137068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Reagents for labeling biomolecules having aldehyde or ketone Moieties'
[patent_app_type] => new
[patent_app_number] => 09/970215
[patent_app_country] => US
[patent_app_date] => 2001-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15817
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137068.pdf
[firstpage_image] =>[orig_patent_app_number] => 09970215
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/970215 | Reagents for labeling biomolecules having aldehyde or ketone moieties | Oct 1, 2001 | Issued |
Array
(
[id] => 6209856
[patent_doc_number] => 20020072467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-06-13
[patent_title] => 'Molded catalyst for production of triethylenediamine, method for its production, and method for producing triethylenediamine'
[patent_app_type] => new
[patent_app_number] => 09/961413
[patent_app_country] => US
[patent_app_date] => 2001-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6620
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20020072467.pdf
[firstpage_image] =>[orig_patent_app_number] => 09961413
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/961413 | Molded catalyst for production of triethylenediamine, method for its production, and method for producing triethylenediamine | Sep 24, 2001 | Issued |
Array
(
[id] => 6407591
[patent_doc_number] => 20020037811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Process for the preparation of 2-alkoxy-6-trifluoromethyl-N-([1,2,4]triazolo[1,5-c]pyrimidin-2-yl)benzenesulfonamides'
[patent_app_type] => new
[patent_app_number] => 09/961617
[patent_app_country] => US
[patent_app_date] => 2001-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2242
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037811.pdf
[firstpage_image] =>[orig_patent_app_number] => 09961617
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/961617 | Process for the preparation of 2-alkoxy-6-trifluoromethyl-N-(1,2,4triazolo1,5-cpyrimidin-2-yl) benzenesulfonamides | Sep 23, 2001 | Issued |